Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton

Bioorg Med Chem Lett. 2000 May 15;10(10):1081-4. doi: 10.1016/s0960-894x(00)00161-x.

Abstract

Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton were prepared and their structure-activity relationships were analyzed. Among them, N-phenyl-4,5,6,7-tetrachlorophthalimide (CPOP: 2) and N-(4-phenylbutyl)-4,5,6,7-tetrachlorophthalimide (CP4P: 6) showed very potent inhibitory activity, being more potent than 1-deoxynojirimycin (dNM: 1). Mechanistic studies revealed that CPOP (2) and CP4P (6) inhibit alpha-glucosidase non-competitively and competitively, respectively.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Deoxynojirimycin / chemistry
  • 1-Deoxynojirimycin / pharmacology
  • Binding Sites
  • Catalytic Domain
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Glycoside Hydrolase Inhibitors*
  • Inhibitory Concentration 50
  • Phthalimides / chemistry*
  • Phthalimides / metabolism
  • Phthalimides / pharmacology*
  • Structure-Activity Relationship
  • alpha-Glucosidases / metabolism

Substances

  • Enzyme Inhibitors
  • Glycoside Hydrolase Inhibitors
  • N-(4-phenylbutyl)-4,5,6,7-tetrachlorophthalimide
  • N-phenyl-4,5,6,7-tetrachlorophthalimide
  • Phthalimides
  • 1-Deoxynojirimycin
  • alpha-Glucosidases